Skip to content

PCN reports : psychiatry and clinical neurosciences

ISSN 2769-2558

8 papers in the library · 43 citations · publishing 2023-2025

Papers

Sort Most recent Most cited

Psychosis induced by invocation presenting as possession state: A case of Kitousei-Seishinbyo still emerging in modern Japan.

PCN reports : psychiatry and clinical neurosciences December 1, 2025 Fumiya Miyano, Nobuyuki Mitsui, Yutaka Fujii et al.

Kitousei-Seishinbyo, or psychosis induced by invocation, was first described by Morita in 1915 as a culture-bound syndrome characterized by possession-like states and personality transformation triggered by prayer or spiritual practices. New psychosocial triggers (e.g., self-improvement seminars, emerging religious groups) have been identified. However, reports of possession-related episodes...

A sense of being inserted by the original self: A distinctive manifestation of delusional misidentification of the self, a case report.

PCN reports : psychiatry and clinical neurosciences December 1, 2025 Akihiro Koreki, Masataka Kaji, Hiroki Oi et al.

Delusional misidentification of the self is a rare psychotic symptom in which individuals misidentify themselves. These symptoms are sometimes accompanied by psychotic renaming, reflecting profound psychological changes in the self. To date, such symptoms have not been fully understood through the lens of the minimal self, especially with respect to the sense of agency (SoA). We report the case...

Comparative efficacy and safety of intravenous racemic ketamine, repetitive transcranial magnetic stimulation and electroconvulsive therapy for Stage 2 or higher treatment-resistant depression: A systematic review and network meta-analysis.

PCN reports : psychiatry and clinical neurosciences September 1, 2025 Itsuki Terao, Takahiro Tsuge, Tomoo Sato et al. 2 citations

Although electroconvulsive therapy (ECT) is the standard treatment for Stage 2 or higher treatment-resistant depression, it has several drawbacks. Repetitive transcranial magnetic stimulation (rTMS) and intravenous racemic ketamine (IV ketamine) have emerged as potential alternatives, but their comparative effectiveness and safety remain unclear due to limited evidence. We systematically...

Psychosis and suicide attempt following a single use of delta-9-tetrahydrocannabiphorol: A case report.

PCN reports : psychiatry and clinical neurosciences March 1, 2025 Daniel Greer, Jennifer Atherton, Justina Girgis

Delta-9-tetrahydrocannabiphorol (Δ9-THCP) is a potent phytocannabinoid found naturally in the cannabis plant in small quantities. This cannabinoid is noted to potently bind to cannabinoid receptor 1 and cannabinoid receptor 2 and is reported to be highly psychoactive. A small amount of Δ9-THCP is found naturally, which led to its isolation and synthetic production. This isolate is beginning to...

Concomitant use of dextromethorphan and alcohol-induced dissociation in a patient with alcohol dependence.

PCN reports : psychiatry and clinical neurosciences December 1, 2024 Yasuhito Nagai, Yuko Tajima, Koichi Miyakawa

Dextromethorphan (DXM) is an over-the-counter drug that is commonly abused by teenagers. Its main pharmacological property is a low-affinity N-methyl-d-aspartate (NMDA) receptor antagonist. We report acute psychotic dissociation induced by DXM and alcohol in a patient with alcohol dependence, which made it difficult to distinguish alcohol withdrawal symptoms with limited information. The...

Exploring perinatal ketamine for postpartum depression following cesarean section: A systematic review.

PCN reports : psychiatry and clinical neurosciences September 1, 2024 Jaylyn Thompson, David F Lo, Alexis Foschini et al. 1 citation

The aim of this study was to explore the use of perinatal ketamine to see if it can be used for the reduction of postpartum depression (PPD) following cesarean section (C-section). PubMed, Cochrane, and Web of Science were the primary databases used for this review. Search terms used on January 5, 2024 incorporated "ketamine," "C-section," "postpartum depression," and related synonyms. The...

Ayahuasca: A review of historical, pharmacological, and therapeutic aspects.

PCN reports : psychiatry and clinical neurosciences December 1, 2023 Simon Ruffell, Max Crosland-Wood, Rob Palmer et al. 37 citations

Ayahuasca is a psychedelic plant brew originating from the Amazon rainforest. It is formed from two basic components, the Banisteriopsis caapi vine and a plant containing the potent psychedelic dimethyltryptamine (DMT), usually Psychotria viridis. Here we review the history of ayahuasca and describe recent work on its pharmacology, phenomenological responses, and clinical applications. There...

Impact of continued mindfulness practice on resilience and well-being in mindfulness-based intervention graduates during the COVID-19 pandemic: A cross-sectional study.

PCN reports : psychiatry and clinical neurosciences September 1, 2023 Chisato Tanaka, Kenta Wakaizumi, Akira Ninomiya et al. 3 citations

The coronavirus disease 2019 (COVID-19) pandemic has caused unprecedented stress. Mindfulness-based interventions (MBIs) are known to be effective in reducing stress. However, it is unclear how long-term outcomes differ between those who continue mindfulness practice after MBIs and those who do not. In this study, we hypothesized that those who continued mindfulness practice would have higher...